NCT04737980View on ClinicalTrials.gov

Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

February 28, 2020

Study Completion Date

March 18, 2020

Conditions
Rotator Cuff TearsShoulder Pain
Interventions
DRUG

Liposomal bupivacaine

Injection of 10 ml of liposomal bupivacaine 1.3% (133 mg) for ultrasound guided interscalene block

DRUG

Bupivacaine Hcl 0.5% Inj

Injection of 10 ml of 0.5% bupivacaine hydrochloride as admixture for ultrasound guided interscalene block

DRUG

Ropivacaine 0.5% Injectable Solution

Injection of 30 ml of ropivacaine 0.5% injectable solution for ultrasound guided interscalene block

DRUG

Dexamethasone

Injection of 8mg (2ml) dexamethasone injectable as admixture

Trial Locations (1)

33401

HSS Florida, West Palm Beach

All Listed Sponsors
lead

Hospital for Special Surgery Florida

OTHER

NCT04737980 - Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair | Biotech Hunter | Biotech Hunter